S*Bio

Pioneering the future of cancer treatment through innovative small molecule drugs.

General Information
Company Name
S*Bio
Founded Year
2000
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
Biotechnology, Pharmaceutical
Funding Stage
Private Equity
Social Media

S*Bio - Company Profile

S*Bio is a Singapore-based biotech company founded in 2000 and operating as a subsidiary of Chiron Corporation Limited. Specializing in Biotechnology and Pharmaceutical industries, the company is focused on pioneering the future of cancer treatment through innovative small molecule drugs. The latest investment of $5.00M through a Private Equity Round took place on 23 September 2010 and was made by Mitsui Global Investment. S*BIO Pte, Ltd. has been dedicated to discovering and clinically developing novel targeted small drugs to treat cancer, serving the biotechnology industry in Singapore.

Taxonomy: biotech industry, cancer treatment, drug discovery, small molecule drugs, Singapore-based, clinical development, targeted therapies, oncology, Chiron Corporation Limited, innovation

Funding Rounds & Investors of S*Bio (3)

View All
Funding Stage Amount No. Investors Investors Date
Private Equity Round $5.00M 1 23 Sep 2010
Venture Round $112.50M 1 Adastra Pharmaceuticals 21 Jan 2009
Venture Round $26.00M 6 Zürcher Kantonal Bank 20 Oct 2008

Latest News of S*Bio

View All

No recent news or press coverage available for S*Bio.

Similar Companies to S*Bio

View All
InvoSystems Solutions Pte Ltd - Similar company to S*Bio
InvoSystems Solutions Pte Ltd Empowering Businesses, Stakeholders, and Individuals for Sustainability & Preventive Health with Mobile Apps & solutions
LOL Corporate - Similar company to S*Bio
LOL Corporate Corporate Services on the Little Red Dot. Offering Free Singapore Company Registration for Qualified Startups.